CLC | Charcot-Leyden crystal galectin | Predicted intracellular proteins
| | | | | Tissue enriched |
CLEC12A | C-type lectin domain family 12, member A | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4G | C-type lectin domain family 4, member G | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CR1 | Complement component (3b/4b) receptor 1 (Knops blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CTSG | Cathepsin G | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CTSW | Cathepsin W | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL8 | Chemokine (C-X-C motif) ligand 8 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR3 | Chemokine (C-X-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
DEFA1 | Defensin, alpha 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
DEFA1B | Defensin, alpha 1B | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
DEFA3 | Defensin, alpha 3, neutrophil-specific | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
DEFA4 | Defensin, alpha 4, corticostatin | Predicted secreted proteins
| | | | | Tissue enriched |
DENND1C | DENN/MADD domain containing 1C | Predicted intracellular proteins
| | | | | Tissue enhanced |
DPPA4 | Developmental pluripotency associated 4 | Predicted intracellular proteins
| | | | | Group enriched |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
EBLN2 | Endogenous Bornavirus-like nucleoprotein 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ELANE | Elastase, neutrophil expressed | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
EPB42 | Erythrocyte membrane protein band 4.2 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
FAM9C | Family with sequence similarity 9, member C | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
FBXO5 | F-box protein 5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FCRL1 | Fc receptor-like 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FCRLA | Fc receptor-like A | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FDCSP | Follicular dendritic cell secreted protein | Predicted secreted proteins
| | | | | Group enriched |
FOXP3 | Forkhead box P3 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
FUT4 | Fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) | Predicted membrane proteins
| | | | | Tissue enriched |
FYB | FYN binding protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
GAL | Galanin/GMAP prepropeptide | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GATA1 | GATA binding protein 1 (globin transcription factor 1) | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
GNLY | Granulysin | Predicted intracellular proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GP1BA | Glycoprotein Ib (platelet), alpha polypeptide | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GP9 | Glycoprotein IX (platelet) | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GPR182 | G protein-coupled receptor 182 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
GRAP2 | GRB2-related adaptor protein 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GSDMC | Gasdermin C | Predicted intracellular proteins
| | | | | Group enriched |
GYPA | Glycophorin A (MNS blood group) | Blood group antigen proteins CD markers Predicted membrane proteins
| | | | | Tissue enriched |
GZMK | Granzyme K (granzyme 3; tryptase II) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
H1FX | H1 histone family, member X | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
HBA1 | Hemoglobin, alpha 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
HBA2 | Hemoglobin, alpha 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
HBD | Hemoglobin, delta | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
HBQ1 | Hemoglobin, theta 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
HEMGN | Hemogen | Predicted intracellular proteins
| | | | | Group enriched |